167 related articles for article (PubMed ID: 19670287)
1. Lack of ABCG2 expression and side population properties in human pluripotent stem cells.
Zeng H; Park JW; Guo M; Lin G; Crandall L; Compton T; Wang X; Li XJ; Chen FP; Xu RH
Stem Cells; 2009 Oct; 27(10):2435-45. PubMed ID: 19670287
[TBL] [Abstract][Full Text] [Related]
2. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
[TBL] [Abstract][Full Text] [Related]
3. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors.
Scharenberg CW; Harkey MA; Torok-Storb B
Blood; 2002 Jan; 99(2):507-12. PubMed ID: 11781231
[TBL] [Abstract][Full Text] [Related]
4. Ocular surface epithelia contain ABCG2-dependent side population cells exhibiting features associated with stem cells.
Budak MT; Alpdogan OS; Zhou M; Lavker RM; Akinci MA; Wolosin JM
J Cell Sci; 2005 Apr; 118(Pt 8):1715-24. PubMed ID: 15811951
[TBL] [Abstract][Full Text] [Related]
5. High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells.
Apáti A; Orbán TI; Varga N; Németh A; Schamberger A; Krizsik V; Erdélyi-Belle B; Homolya L; Várady G; Padányi R; Karászi E; Kemna EW; Német K; Sarkadi B
Biochim Biophys Acta; 2008 Dec; 1778(12):2700-9. PubMed ID: 18793608
[TBL] [Abstract][Full Text] [Related]
6. Expression of a Hoechst 33342 efflux phenomenon and common characteristics of pluripotent stem cells in a side population of amniotic fluid cells.
Tsai YL; Chang YJ; Chou CY; Cheong ML; Tsai MS
Taiwan J Obstet Gynecol; 2010 Jun; 49(2):139-44. PubMed ID: 20708517
[TBL] [Abstract][Full Text] [Related]
7. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
8. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.
Ozvegy C; Váradi A; Sarkadi B
J Biol Chem; 2002 Dec; 277(50):47980-90. PubMed ID: 12374800
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of side population cells from adult human dental pulp after ischemic culture.
Wang J; Wei X; Ling J; Huang Y; Gong Q; Huo Y
J Endod; 2012 Nov; 38(11):1489-97. PubMed ID: 23063223
[TBL] [Abstract][Full Text] [Related]
10. Multipotent stem cells in human corneal stroma.
Du Y; Funderburgh ML; Mann MM; SundarRaj N; Funderburgh JL
Stem Cells; 2005 Oct; 23(9):1266-75. PubMed ID: 16051989
[TBL] [Abstract][Full Text] [Related]
11. Methoxy stilbenes as potent, specific, untransported, and noncytotoxic inhibitors of breast cancer resistance protein.
Valdameri G; Pereira Rangel L; Spatafora C; Guitton J; Gauthier C; Arnaud O; Ferreira-Pereira A; Falson P; Winnischofer SM; Rocha ME; Tringali C; Di Pietro A
ACS Chem Biol; 2012 Feb; 7(2):322-30. PubMed ID: 22039929
[TBL] [Abstract][Full Text] [Related]
12. Olomoucine II and purvalanol A inhibit ABCG2 transporter in vitro and in situ and synergistically potentiate cytostatic effect of mitoxantrone.
Hofman J; Ahmadimoghaddam D; Hahnova L; Pavek P; Ceckova M; Staud F
Pharmacol Res; 2012 Mar; 65(3):312-9. PubMed ID: 22173067
[TBL] [Abstract][Full Text] [Related]
13. Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase.
Ji N; Yuan J; Liu J; Tian S
Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):854-62. PubMed ID: 21106767
[TBL] [Abstract][Full Text] [Related]
14. Generation of multidrug resistant human tissues by overexpression of the ABCG2 multidrug transporter in embryonic stem cells.
Erdei Z; Schamberger A; Török G; Szebényi K; Várady G; Orbán TI; Homolya L; Sarkadi B; Apáti Á
PLoS One; 2018; 13(4):e0194925. PubMed ID: 29649238
[TBL] [Abstract][Full Text] [Related]
15. ABCG2 is required to control the sonic hedgehog pathway in side population cells with stem-like properties.
Balbuena J; Pachon G; Lopez-Torrents G; Aran JM; Castresana JS; Petriz J
Cytometry A; 2011 Sep; 79(9):672-83. PubMed ID: 21774076
[TBL] [Abstract][Full Text] [Related]
16. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
17. In vitro and ex vivo anti‑tumor effect and mechanism of Tucatinib in leukemia stem cells and ABCG2‑overexpressing leukemia cells.
Jing W; Zhou M; Chen R; Ye X; Li W; Su X; Luo J; Wang Z; Peng S
Oncol Rep; 2021 Mar; 45(3):1142-1152. PubMed ID: 33650639
[TBL] [Abstract][Full Text] [Related]
18. Guanosine-induced decrease in side population of lung cancer cells: lack of correlation with ABCG2 expression.
Su C; Picard P; Rathbone MP; Jiang S
J Biol Regul Homeost Agents; 2010; 24(1):19-25. PubMed ID: 20385068
[TBL] [Abstract][Full Text] [Related]
19. Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition.
Ozvegy-Laczka C; Köblös G; Sarkadi B; Váradi A
Biochim Biophys Acta; 2005 Feb; 1668(1):53-63. PubMed ID: 15670731
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
Doyle L; Ross DD
Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
